Opaleye Management Inc.'s Form 4 filing
Eton Pharmaceuticals, Inc. (ETON) · filed Jun 12, 2025
- Accession no.
- 0001641172-25-014868
- Filed
- Jun 12, 2025
- Trade date
- Jun 10, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $125.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2025 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +5,000 | $15.82 | +$79,100 | 2,770,000 | Indirect | |
| Jun 10, 2025 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +2,930 | $15.82 | +$46,352.6 | 85,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.